JAMES MORGAN: Open Payments
NPI 1578018107 · HAUPPAUGE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,630 in 71 payments from 9 companies in 2025. Trend: 2023 $1,244 · 2024 $1,113 · 2025 $1,630
Food & beverage: $1,630
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $339 |
| ABBVIE INC. | 11 | $281 |
| Alkermes, Inc. | 9 | $277 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $265 |
| Otsuka America Pharmaceutical, Inc. | 8 | $156 |
| Lundbeck LLC | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Bausch Health US, LLC | 4 | $70 |
Products named: Auvelity, VRAYLAR, ARISTADA, TRINTELLIX, REXULTI, CAPLYTA, HETLIOZ, APLENZIN.
Industry payments across NY — which companies pay providers there.
